2-氨基异丁酸乙酯盐酸盐 | 17288-15-2

• 物质功能分类: 生物化工 - 氨基酸及其衍生物 - 氨基酸盐
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 2-氨基异丁酸乙酯盐酸盐
• 中文别名: H-Aib-OEt・HCl；2-甲基丙氨酸乙酯盐酸盐
• 英文名称: ethyl 2-aminoisobutyrate hydrochloride
• 英文别名: ethyl 2-amino-2-methylpropanoate hydrochloride；ethyl 2-amino-2-methylpropionate hydrochloride；2-aminoisobutyric acid ethyl ester hydrochloride；ethyl 2-methylalaninate hydrochloride；ethyl gem-dimethyl 3-amino propanoic acid hydrochloride；α-Amino-isobuttersaeureethylesterhydrochlorid；1-ethoxycarbonyl-1-methylethylamine hydrochloride；ethyl 2-amino-2-methylpropanoate;hydrochloride
• CAS: 17288-15-2
• 化学式: C₆H₁₄NO₂*Cl
• mdl: MFCD06809830
• 分子量: 167.636
• InChiKey: YREPHXXOTHNLEV-UHFFFAOYSA-N

物化性质

• 熔点：
  156-157 °C

计算性质

• 辛醇/水分配系数(LogP)：
  0.36
• 重原子数：
  10
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.833
• 拓扑面积：
  52.3
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2922499990
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  存储温度应保持在0-5°C。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: H-Aib-OEt HCl
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: H-Aib-OEt HCl
CAS number: 17288-15-2

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H13NO2.ClH
Molecular weight: 167.6

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-氨基异丁酸乙酯盐酸盐 在 sodium tetrahydroborate 、 溶剂黄146 、 三乙胺 作用下， 以 甲苯 为溶剂， 反应 22.5h， 生成 ethyl 2-[(2,3-dichloro-6-nitrobenzyl)amino]isobutyrate hydrochloride
  参考文献：
  名称：

  [EN] PROCESS FOR THE PREPARATION OF ANAGRELIDE AND ANALOGUES THEREOF
  [FR] PROCÉDÉ DE PRÉPARATION D'ANAGRÉLIDE ET DE SES ANALOGUES

  摘要：

  本发明涉及一种生产阿格雷利特、6,7-二氯-1,5-二氢咪唑[2,1-b]喹唑啉-2(3H)-酮或其某些类似物的新工艺。该发明的工艺还提供了生产阿格雷利特或其某些类似物所需的关键中间体的改进工艺。

  公开号：

  WO2012052781A1
• 作为产物：
  描述：

  2-甲基丙氨酸 以 乙醇 为溶剂， 生成 2-氨基异丁酸乙酯盐酸盐
  参考文献：
  名称：

  1,3-oxazin-4-one derivatives as herbicides

  摘要：

  式(I)的1,3-噁唑啉-4-酮，其中R.sup.1代表苯基，可以选择性地被取代；R.sup.2代表：具有1到10个碳原子的直链或支链烷基，该烷基被一个或多个R.sup.8基团取代，这些基团可以相同也可以不同；具有最多十个碳原子的直链或支链可选择性卤代烯烃或炔烃基团；或者从氰基，--CHO，--COR.sup.7，--CO.sub.2 H，--CO.sub.2 R.sup.7，--COSR.sup.7，--CONR.sup.9 R.sup.10，--CH.dbd.NOH，--CH.dbd.NOR.sup.7，--CH.dbd.NOCOR.sup.7，--CH.dbd.NNR.sup.9 R.sup.10，--CH.sub.2 CN，--CH.sub.2 NO.sub.2和环氧乙基中选择的基团；R.sup.3代表苯基，可以选择性地被取代，或者R.sup.3代表第一个五到七元杂环芳烃环；所述第一个环可以选择性地融合，所述第一个环通过其中一个环碳原子与基团NR.sup.6的氮原子连接；R.sup.4和R.sup.5独立地代表较低的烷基；W代表--NR.sup.6--；R.sup.6代表氢，较低的烷基，卤代烷基，烯烃基，炔烃基，--COR.sup.7或--CO.sub.2 R.sup.7；以及它们作为除草剂的用途。

  公开号：

  US06028032A1

文献信息

• [EN] PHOSPHONIC ACID DERIVATES AND THEIR USE AS P2Y12 RECEPTOR ANTAGONISTS<br/>[FR] DÉRIVÉS D'ACIDE PHOSPHONIQUE ET LEUR UTILISATION EN TANT QU'ANTAGONISTES DU RÉCEPTEUR P2Y12
  申请人：ACTELION PHARMACEUTICALS LTD

  公开号：WO2009069100A1

  公开（公告）日：2009-06-04

  The invention relates to 2-phenyl-pyrimidine derivatives containing a phosphonic acid motif and their use as P2Y12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals. (I).

  这项发明涉及含有膦酸基团的2-苯基嘧啶衍生物，以及它们作为P2Y12受体拮抗剂在治疗和/或预防外周血管、内脏-、肝脏和肾脏血管、心血管和脑血管疾病或与血小板聚集有关的疾病或状况中的使用，包括人类和其他哺乳动物中的血栓形成。（I）。
• Novel Thiazole Inhibitors of Fructose 1,6-Bishosphatase
  申请人：Dang Qun

  公开号：US20070225259A1

  公开（公告）日：2007-09-27

  Compounds of Formula I, their prodrugs and salts, their preparation and their uses are described.

  公式I的化合物，它们的前药和盐，它们的制备以及它们的用途被描述了。
• FUROISOQUINOLINE DERIVATIVE AND USE THEREOF
  申请人：Takeda Pharmaceutical Company Limited

  公开号：EP1541576A1

  公开（公告）日：2005-06-15

  The present invention provides a compound represented by the formula    wherein A represents (1) a bond, (2) a group represented by the formula -CRa=CRb- (Ra and Rb each represent a hydrogen atom or C1-6 alkyl) and the like; R1 represents (1) cyano or (2) an optionally esterified or amidated carboxyl group; R2 represents (1) a hydrogen atom, (2) an optionally substituted hydroxy group, (3) an optionally substituted amino group and the like; R3 and R4 each represent a hydrogen atom and the like; R5 represents a hydrogen atom and the like; R6 represents an optionally substituted hydroxy group and the like; R7and R8 each represent an optionally substituted hydrocarbon group and the like; R9 and R10 each represent (1) a hydrogen atom and the like; Y represents an optionally substituted methylene group; and n represents 0 or 1, or a salt thereof, which has an excellent phosphodiesterase IV inhibiting action.

  本发明提供了一种化合物，其表示为式中的化合物，其中A代表（1）键，（2）由式 -CRa=CRb-（Ra和Rb分别代表氢原子或C1-6烷基等）表示的基团等；R1代表（1）氰基或（2）可选择酯化或酰胺化的羧基；R2代表（1）氢原子，（2）可选择取代的羟基，（3）可选择取代的氨基等；R3和R4各自代表氢原子等；R5代表氢原子等；R6代表可选择取代的羟基等；R7和R8各自代表可选择取代的碳氢基团等；R9和R10各自代表（1）氢原子等；Y代表可选择取代的亚甲基基团；n代表0或1，或其盐，具有优异的磷酸二酯酶IV抑制作用。
• Condensed pyridazine derivatives, their production and use
  申请人：Takeda Chemical Industries, Ltd.

  公开号：US06627630B1

  公开（公告）日：2003-09-30

  A condensed pyridazine derivative which is useful as a pharmaceutical composition for preventing or treating allergic skin diseases such as contact dermatitis, pruritus, dried dermatitis, acute urticaria and prurigo.

  一种浓缩的吡啶嗪衍生物，可用作预防或治疗过敏性皮肤病，如接触性皮炎、瘙痒、干性皮炎、急性荨麻疹和疥疮的药物组合物。
• Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
  申请人：G.D. Searle & Co.

  公开号：US06337398B1

  公开（公告）日：2002-01-08

  Succinoylamino hydroxyethylamino sulfonyl urea derivatives of the formula: wherein the substituents are as defined in the specification, are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.

  丁酰氨基羟基乙氨基磺酰脲衍生物的公式如下： 其中，取代基的定义如说明书所述，这些衍生物作为逆转录病毒蛋白酶抑制剂是有效的，尤其是作为HIV蛋白酶的抑制剂。